- Current report filing (8-K)
January 25 2012 - 4:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 25, 2012
|
ROCHESTER MEDICAL CORPORATION
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Minnesota
|
|
0-18933
|
|
41-1613227
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
One Rochester Medical Drive, Stewartville, MN 55976
|
(Address of principal executive offices, including zip code)
Registrants telephone number, including area code: (507) 533-9600
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
The following information is being furnished in accordance with General Instruction B.2 of Form 8-K and shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such filing.
Furnished herewith as Exhibit 99.1 and
incorporated by reference herein is the text of Rochester Medical Corporations (the Company) announcement regarding operating results for the quarter ended December 31, 2011, as presented in a press release dated
January 25, 2012.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
Exhibits.
The following information is being furnished in accordance with General Instruction B.2 of Form 8-K and shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
|
|
|
|
|
99.1
|
|
Press release dated January 25, 2012, of Rochester Medical Corporation
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: January 25, 2012
|
|
|
ROCHESTER MEDICAL CORPORATION
|
|
|
By:
|
|
/s/ David A. Jonas
|
|
|
David A. Jonas
Chief
Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release dated January 25, 2012 of Rochester Medical Corporation
|
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Apr 2024 to May 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2023 to May 2024